TWA
TCI Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3
| Closed | -$26 | – | 423 |
|
|
2023
Q1 | $26 | Sell |
3
-430
| -99% | -$3.73K | ﹤0.01% | 2476 |
|
|
2022
Q4 | $4.97K | Sell |
433
-3
| -0.7% | -$34 | ﹤0.01% | 1528 |
|
|
2022
Q3 | $5K | Buy |
436
+6
| +1% | +$69 | ﹤0.01% | 1425 |
|
|
2022
Q2 | $5K | Sell |
430
-381
| -47% | -$4.43K | ﹤0.01% | 1443 |
|
|
2022
Q1 | $13K | Hold |
811
| – | – | ﹤0.01% | 914 |
|
|
2021
Q4 | $11K | Buy |
811
+177
| +28% | +$2.4K | ﹤0.01% | 1072 |
|
|
2021
Q3 | $9K | Buy |
634
+487
| +331% | +$6.91K | ﹤0.01% | 1127 |
|
|
2021
Q2 | $2K | Sell |
147
-51
| -26% | -$694 | ﹤0.01% | 1936 |
|
|
2021
Q1 | $2K | Buy |
+198
| New | +$2K | ﹤0.01% | 1655 |
|